Ethanol/lipid metabolism, dysfunction of ion transport, and pathogenesis of alcoholic pancreatitis

乙醇/脂质代谢、离子转运功能障碍与酒精性胰腺炎的发病机制

基本信息

  • 批准号:
    15590638
  • 负责人:
  • 金额:
    $ 1.86万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2005
  • 项目状态:
    已结题

项目摘要

1. Mutations and polymorphisms (TG repeats, poly T, M470V, Q1352H, R1453W) of CFTR (cystic fibrosis transmembrane conductance regulator) were examined in Japanese patients with chronic pancreatitis. None of the cystic fibrosis-causing mutations were detected. Frequency of the genotype TG(12/12) was higher in alcoholic pancreatitis. Frequency of the genotype V470/V470 was higher in idiopathic pancreatitis.2. To estimate CFTR Cl^- channel function, we established "finger sweat chloride test" to measure Cl^- concentration in insensible sweat, which sweat is collected by holding a small tube containing 100 μl water with the thumb and the sweat rate is measured by a perspiration meter. The Cl^- content in the sample is measured by capillary electrophoresis or more easily by a highly sensitive electrode.3. The activity of Na^+-H^+ exchange (NHE) in the apical membrane was examined in luminally-microperfused interlobular pancreatic duct segments isolated from ΔF mice, a cystic fibrosis model. The apical NHE activity significantly increased in ΔF/ΔF ducts, which may cause pH decrease of pancreatic juice.4. Effects of a series of short-chain alcohols (methanol, ethanol, propanol, and butanol) on cAMP-stimulated fluid secretion and intracellular Ca^<2+> concentration were examined in interlobular pancreatic duct segments isolated from guinea-pig. Methanol and ethanol enhanced fluid secretion and caused a transient increase of intracellular Ca^<2+>. On the contrary, propanol and butanol inhibited fluid secretion and lowered intracellular Ca^<2+>. This "cut-off effect" suggests alcohols act directly on some ion channels of pancreatic duct cells.
1.在日本慢性胰腺炎患者中检查了CFTR(囊性纤维化跨膜电导调节因子)的突变和多态性(TG重复、poly T、M470V、Q1352H、R1453W)。没有检测到任何导致囊性纤维化的突变。酒精性胰腺炎中TG(12/12)基因型频率较高。 V470/V470基因型在特发性胰腺炎中出现频率较高。2.为了估计CFTR Cl^-通道功能,我们建立了“指汗氯化物测试”来测量无感汗液中的Cl^-浓度,用拇指握住装有100μl水的小管收集汗液,并通过排汗计测量出汗率。样品中的Cl^-含量通过毛细管电泳或更容易地通过高灵敏电极来测量。3.在从囊性纤维化模型 ΔF 小鼠中分离的管腔微灌注小叶间胰管段中检查了顶膜中 Na^+-H^+ 交换 (NHE) 的活性。 ΔF/ΔF管顶端NHE活性显着升高,可能导致胰液pH值降低。4.在从豚鼠分离的小叶间胰管段中检查了一系列短链醇(甲醇、乙醇、丙醇和丁醇)对cAMP刺激的液体分泌和细胞内Ca 2+ 浓度的影响。甲醇和乙醇增强液体分泌并导致细胞内Ca 2+ 短暂增加。相反,丙醇和丁醇抑制液体分泌并降低细胞内Ca 2+ 。这种“截止效应”表明酒精直接作用于胰管细胞的某些离子通道。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
膵の重炭酸イオン分泌傷害と膵嚢胞線維症/慢性膵炎
胰腺碳酸氢根离子分泌损伤与胰腺囊性纤维化/慢性胰腺炎
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    石黒 洋;他
  • 通讯作者:
A finger sweat chloride test for the detection of a high-risk group of chronic pancreatitis.
用于检测慢性胰腺炎高危人群的指汗氯化物测试。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Naruse S;et al.
  • 通讯作者:
    et al.
DYSFUNCTION OF PANCREATIC HCO3??? SECRETION AND PATHOGENESIS OF CYSTIC FIBROSIS/CHRONIC PANCREATITIS
胰腺 HCO3 功能障碍???
  • DOI:
    10.1097/01.mpa.0000278658.65221.83
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    H. Ishiguro;S. Naruse;T. Kondo;A. Yamamoto
  • 通讯作者:
    A. Yamamoto
膵の重炭酸イオン分泌障害と膵嚢胞線維症/慢性膵炎
胰腺碳酸氢根离子分泌障碍与胰腺囊性纤维化/慢性胰腺炎
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    石黒 洋;成瀬 達;近藤孝晴;山本明子
  • 通讯作者:
    山本明子
Dual effects of n-alcohols on fluid secretion from guinea pig pancreatic ducts.
正型醇对豚鼠胰管液体分泌的双重影响。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KONDO Takaharu其他文献

KONDO Takaharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KONDO Takaharu', 18)}}的其他基金

Molecular pathogenesis of the mucosal lesion due to the dysfunction of NHE3-CFTR transportsome
NHE3-CFTR转运体功能障碍导致黏膜病变的分子发病机制
  • 批准号:
    21590332
  • 财政年份:
    2009
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathophysiology of mucosal lesion caused by defects of epithelial HCO_3^--CO_2 transport
上皮HCO_3^--CO_2转运缺陷引起的粘膜病变的病理生理学
  • 批准号:
    19590303
  • 财政年份:
    2007
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
COLONIC FERMENTATION AND GASTROINTESTINAL SYMPTOMS
结肠发酵和胃肠道症状
  • 批准号:
    08680015
  • 财政年份:
    1996
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Investigating the use of a novel Dualase (dual-endonuclease) system in repairing nonsense mutations and restoring CFTR expression in cystic fibrosis mouse and human airway models
研究使用新型 Dualase(双核酸内切酶)系统修复囊性纤维化小鼠和人类气道模型中的无义突变并恢复 CFTR 表达
  • 批准号:
    486584
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Studentship Programs
A personalised approach to manage adverse reactions to CFTR modulator therapy in patients with cystic fibrosis
治疗囊性纤维化患者 CFTR 调节剂治疗不良反应的个性化方法
  • 批准号:
    MR/X00094X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Research Grant
Personalized management of cystic fibrosis transmembrane regulator (CFTR) modulator therapy in allergic patients.
过敏患者囊性纤维化跨膜调节剂(CFTR)调节剂治疗的个性化管理。
  • 批准号:
    2749971
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Studentship
Patient-derived Model Systems to Assess the in vitro Efficacy of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapies in Cystic Fibrosis
用于评估囊性纤维化跨膜电导调节器 (CFTR) 调节剂治疗囊性纤维化的体外疗效的患者衍生模型系统
  • 批准号:
    459044
  • 财政年份:
    2021
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Studentship Programs
Development of innovative therapeutic strategies in cystic fibrosis for improvement of CFTR-targeted treatments and restoration of airway epithelial integrity in infected lungs from patients harboring various mutations
开发囊性纤维化的创新治疗策略,以改善 CFTR 靶向治疗并恢复携带各种突变的患者感染肺部的气道上皮完整性
  • 批准号:
    443897
  • 财政年份:
    2021
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Operating Grants
Evaluating CFTR-function and response to new CFTR modulator drugs in non-cystic fibrosis patients with CFTR-related lung disease
评估患有 CFTR 相关肺部疾病的非囊性纤维化患者的 CFTR 功能和对新型 CFTR 调节药物的反应
  • 批准号:
    435003
  • 财政年份:
    2020
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Operating Grants
Role of the cystic fibrosis transmembrane conductance regulator (CFTR) in intestinal homeostasis
囊性纤维化跨膜电导调节器(CFTR)在肠道稳态中的作用
  • 批准号:
    434459
  • 财政年份:
    2020
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Operating Grants
Physiological role of CFTR interaction receptor under sterile inflammatory response in cystic fibrosis
CFTR相互作用受体在囊性纤维化无菌炎症反应中的生理作用
  • 批准号:
    19K16508
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Discovery of novel mechanisms that impact CFTR translation and contribute to cystic fibrosis pathogenesis
发现影响 CFTR 翻译并导致囊性纤维化发病机制的新机制
  • 批准号:
    10367064
  • 财政年份:
    2017
  • 资助金额:
    $ 1.86万
  • 项目类别:
Discovery of novel mechanisms that impact CFTR translation and contribute to cystic fibrosis pathogenesis
发现影响 CFTR 翻译并导致囊性纤维化发病机制的新机制
  • 批准号:
    10545091
  • 财政年份:
    2017
  • 资助金额:
    $ 1.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了